V-Square Quantitative Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.94M Sell
46,239
-892
-2% -$104K 0.56% 22
2026
Q1
$5.67M Buy
47,131
+1,824
+4% +$211K 0.6% 18
2025
Q4
$4.77M Sell
45,307
-6,541
-13% -$614K 0.5% 24
2025
Q3
$4.35M Buy
51,848
+4,698
+10% +$387K 0.73% 20
2025
Q2
$3.73M Sell
47,150
-7,914
-14% -$629K 0.5% 28
2025
Q1
$4.94M Buy
55,064
+2,072
+4% +$193K 0.72% 16
2024
Q4
$5.27M Buy
52,992
+838
+2% +$86.4K 0.75% 16
2024
Q3
$5.92M Buy
52,154
+3,715
+8% +$441K 0.87% 14
2024
Q2
$6M Sell
48,439
-4,306
-8% -$555K 0.97% 12
2024
Q1
$6.96M Buy
52,745
+10,614
+25% +$1.31M 0.97% 12
2023
Q4
$4.59M Buy
42,131
+16,298
+63% +$1.69M 0.81% 13
2023
Q3
$2.66M Buy
25,833
+3,319
+15% +$358K 1.17% 9
2023
Q2
$2.6M Buy
22,514
+1,930
+9% +$219K 1.9% 7
2023
Q1
$2.19M Buy
+20,584
New +$2.22M 2.02% 10

Other funds holding MRK

V-Square Quantitative Management's MRK Position: Q2 2026 in Review

V-Square Quantitative Management reduced its Merck (MRK) stake by 1.9% in Q2 2026, selling an estimated $104K and leaving 46,239 shares worth $5.94M. The position accounts for 0.56% of the portfolio, ranked #22.

V-Square Quantitative Management first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.96M in Q1 2024. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • V-Square Quantitative Management held 46,239 shares of Merck worth $5.94M as of Q2 2026.
  • V-Square Quantitative Management sold 892 Merck shares in Q2 2026, an estimated $104K.
  • Merck made up 0.56% of V-Square Quantitative Management's portfolio in Q2 2026, its #22 holding.
  • V-Square Quantitative Management first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • V-Square Quantitative Management's Merck position peaked at $6.96M in Q1 2024.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.